Is Arizona attorney Ron Logan aiding international penny stock fraud ? : AZ IMC

Below are two posts from offshorebusiness.com message board:

http://www.offshorebusiness.com/message_board.asp

They are written by a Mr. Ron Logan of Logan & Geotas, PLC,Phoenix, Arizona,the Arizona attorney for the Bellador Group,(http://www.belladorgroup.com), a boiler room operation located in Kuala Lumpur and Dubai, etc and a Mr.Taylor from that boiler room, or penny stock sales goup itself.

These types of questionable penny stock operators are allowed to deal in U.S.penny stocks to the detriment of U.S. and other retail investors and shares are not generally audited by the SEC that looks the other way so far.

Note that Bellador's Arizona attorney Logan lauds the corrupt,even criminal,management of Mr.Dwight Cantrell and Mr.Robert Johnson of Endovasc in Montgomery, Texas and has the nerve to claim the company is being 'naked shorted',meaning non-existent shares are being dumped by some unnamed party or broker.

'Bellador has been a strong supporter of the efforts of Endovasc to fight the naked shorting.'

- Belladorgroup.com Attorney Ron Logan

The sad truth is that Endovasc,Bellador Group and the corrupt Nevada Agency and Trust Company of former SEC employee Alexander Walker, who received at least $200,000 in free shares as an insider to their illegal pump and dump scam, all worked together to conceal the 'float' or number of shares available to be bought and sold as they themselves promoted the company with press releases etc.and all dumped or sold shares in collusion while hiding this fact from retail investors.

Which is to say those who bought at market price from brokers such as Schwab Capital, Ameritrade, etc.,were ripped off.No retail investor had a chance to compete with their free or steeply discounted offshore shares or to even know they were dumping millions,even tens of millions, of new shares while fraudulently claiming brokers like Charles Schwab were 'naked shorting' their company's stock as an excuse to justify or divert attention from the true reason for the collapse of share price and thus loss of retail investors money as shares became worthless !!!

Besides defrauding naive,unsophisticated investors, including myself,this is also a conduit for laundering money and the SEC and U.S.government continue to let the fraud go on.Even Ollie North used and bought and sold penny stocks during the Iran-Contra days.Could it be that certain levels of our own government know they are rewarding and aiding an international mafia who deal with and launder with these U.S.penny stock shares ? Certainly the SEC and U.S. CONGRESS IS NOT THAT NAIVE.

Very thoughtful business writers have brought this up,particularly Christopher Byron of Rupert Murdoch's N.Y.Post.But on the other hand Murdoch's former employee from London Financial Times,the Lord Rees-Mogg,has been connected to the National Taxpayers Union founder James Dale Davidson for many years.

Both Davidson and the Lord Rees-Mogg have been investors with LOM of Bermuda that has attracted attention from the SEC for huge penny stock frauds.In fact it is now clear that Charles Schwab as well as lessor known brokers and market makers such as vFinance in Florida aided them by providing for accounts to dump and manipulate huge amounts of U.S. penny STOCKS FROM, AT THE EXPENSE OF DEFRAUDING U.S.RETAIL PURCHASERS.

James Dale Davidson and the Lord Rees-Mogg recommended LOM to wealthy investors for offshore investing in their book,The Sovereign Individual', without disclosing their substantial interest. And recently it has come to light that Mr.Davidson, friend to Steve Forbes and other far right Beltway insiders including no doubt Grover Norquist an ex-Executive Director of National Taxpayers Union that Davidson founded in 1969 , has Middle East and Dubai business connections and no doubt U.S.penny stock deals as well.

Mr.James Dale Davidson probably also knows Utah Senator Bennett as well who made an erroneous claim to the SEC earlier this year about a fraudulent penny stock pump and dump scheme called Global Links(GBLL) being the victim of 'naked short selling'.

Further Mr.James Dale Davidson,who likes to hide behind a pseudo patriotism as he defrauds Americans in a myriad of penny stock scams,is founder of 'NAANSS' , or 'National Association Against Naked Short Selling',a fraudulent website since closed down,(probably due to my and others complaints to the SEC),that was used to promote the very scam I have tried to explain above to pump and dump penny stocks and possibly launder money.It was housed in the very same Blaine,Washington office in 2002-2003 that he and at least one convicted Canadian securities fraudster,Brent Pierce, promoted the Genemax penny stock scam from.

And I suspect he was behind an ad paid for by Patrick Byrne of Overstock.com of Utah and an anonymous group called http://www.ncans.net headed by an unidentified individual using the pseudonym 'Bob O'Brien'.They've actualy made threats to me as well as a hedge fund manager,Marc Cohodes,over on the Yahoo NFI message board.

Links at bottom to stories on 'James Angel, Georgetown aids penny stock fraud' and Senator Bennett,penny stock scam,Cheetah Club' discuss that group and a $100,000+ ad-letter to President Bush et.al., placed in the Washington Post on February 8 claiming 'naked shorting' a serious threat to investing in the markets.

In my case with,Endovasc,I'm sorry to say even Stanford University was in on and benfitted from the fraud.The patent promoted by Endovasc to lure investors such as myself came from Stanford which inspired confidence in the company,at least in my case.Stanford as well as two professors Heeschen and Cooke made out like bandits from a 'nicotine patent' promoted as a breakthrough discovery to induce angiogenesis or blood vessel growth.Only recently did the scandal and my complaints become enough for Stanford to withdraw their patent,too late to avoid massive stock fraud by the ongoing biotech scam called Endovasc in Montgomery, Texas and incorporated in Nevada whose corporate laws attract this paricular form of crime.

Dear Mr.Ron Logan,

Below are your statements from offshorebusiness.com message board about Bellador Group,James Dale Davidson,Endovasc, and 'naked shorting'.I would like to ask you why your client Bellador Group of Kuala Lumpur,Dubai,etc.,and
Mr.Taylor,et.al. did not disclose or have their Endovasc deal disclosed on Endovasc SEC filings.If you are indeed so concerned about 'naked shorting' shouldn't you be concerned about your client's disclosure or lack thereof of shares they controlled and at what price ?

Are you not concerned about the 'Endovasc scam warning' placed on the http://www.belladorgroup.com
website in early 2004 claimiing an unknown person or group was running an international stock swap scam using Endovasc and AMD shares and requiring an up front fee be deposited at a California bank that would then be wired to Nicosia or Cypress of all places ? Wouldn't getting to the bottom of such criminality using your client's own name be a better use of your time as opposed to harassing critics on message boards ?And coincidentally using both the Bellador's name and Mr.Taylor's name to do it ? Are you sure that your client Mr.Taylor of Bellador Group and the other Mr.Taylor of Bellador were not one and the same ?

And as you,Mr.Ron Logan,went out of your way to quote my statement regarding James Dale Davidson
on the offshorebusiness.com website and defended him against me with little reason or information to judge my circumstances or the frauds Mr.Davidson perpetrated at Endovasc and Genemax using an erroneous 'naked shorting' claim to mask his own insider and illegal pumps and dumps and manipulation of those same penny stocks ,why did you take Mr.Davidson's side,who you claim not to even know ?

Does Bellador Group have any involvement with Mr.Davidson or Amenni in Dubai or elsewhere ?
Was Mr.Davidson involved still with Endovasc and its shares when Bellador became involved with Endovasc ? And finally what do you base your claim upon that Endovasc was 'naked shorted' ? What is your proof ? It is an outrageous claim to cover up illegal pump and dump activities by Mr.James Dale Davidson and Endovasc 'management' and apparently used by Bellador Group management as well. Why has your client Bellador Group,who admits a deal with Dwight Cantrell and Robert Johnson of Endovasc,not disclosed that deal to defrauded American investors ?

What follows, in addition to the Bellador Group's 'Endovasc scam warning' posted on their website in 2004, is one of your most pertainent offshorebusiness.com message board posts and one from your client,Mr.Taylor,using the message board against David Marchant's wishes to tout or promote
Bellador Group,no doubt just as he touts U.S. penny stocks to foreign and offshore 'investors'. Do you
know if any of the Endovasc shares pertaining to Bellador Group entered the U.S. market by way of vFinancial ?

I will add my further communication with Judge Ken Reilly Reilly and part of the SEC filing the I think
pertains to Bellador's Endovasc shares as an add on commentary to this news-opinion post below.
Sincerely
Tony Ryals

.....................................................................................

'Bellador has been a strong supporter of the efforts of Endovasc to fight the naked shorting.'

Bellador attorney Ron Logan

http://www.offshorebusiness.com/message_board_detail.asp?id=14062&page=4

Reply Re: Bellador boiler room, Endovasc,Advanced Micro Devices,etc.
By Ron Logan on 11/10/2004 4:06:36 AM
E-mail: logan@logan-geotas.com

Sir:

It is always troubling when anonymous, uninformed, message board "experts" make posts such as the following:

"The question remains as to why James Dale Davidson who founded 'naanss' supposedly to 'stop naked short selling' with convicted Canadian securities fraudster Brent Pierce,and who must have dumped many unaccounted for shares when he pumped through his 'Vantage Point' etc. wasn't included in this group of insider share dumpers.Nor Belladorgroup boiler room boys out of Kuala Lumpur for that matter."

I have no connection with, or special knowledge of, the other parties that you mention, but I am well informed about Bellador Advisory Services (Labuan) Limited and its operations. You are completely wrong about your accusations of short selling and regarding your claim that Bellador operates a boiler room. Your post suggests that you are do not understand what an insider is, what a boiler room is and what constitutes commercial defamation.

1. Bellador Advisory Services (Labuan) Limited owns no shares in Endovasc, Inc.

2. Bellador Advisory Services (Labuan) Limited is not a boiler room. It is a research firm and financial advisor that screens well over 60 public companies for each one that it recommends to its high net worth clients around the globe. It has an extensive due diligence system that identifies late development stage and early revenue stage companies that are expected to become highly profitable. Bellador looks for companies that occupy a unique place in their industry, have strong intellectual property protection on exciting products, can become very successful with a modest amount of capital and that have a strong management team which has a strong plan for success.

Endovasc is one of those companies. The screening, information gathering and analysis performed by Bellador's due diligence team is followed by the preparation of a report on each opportunity that is more extensive in some respects than analyst reports that are produced by major brokerage houses. Bellador, in addition to conducting research to fully understand a funding candidate's industry, undertakes careful financial due diligence, conducts extensive interviews of all key employees, examines all important contracts to which the company has entered into and requires contract terms that allow for careful monitoring of the use of proceeds. Your complete misunderstanding of Bellador brings your own credibility into question.

3. Bellador's directors, not the company itself, have invested in some companies funded by its clients, but neither Bellador nor its directors have ever sold, shorted or otherwise engaged in hedging transactions involving a single share of any funded company. Bellador is subject to exhaustive audits by the licensing authority in Labuan, the Federal Territory of Malaysia (a growing financial center in East Malaysia). Any interested party can contact the Labuan Offshore Financial Services Authority (LOFSA) and will find that Bellador Advisory Services is licensed as a fund manager and advisor and has been thoroughly audited by both LOFSA and by the Malaysia Securities Commission within the past year. The audit is intended to assure that Bellador has complied fully with the strict laws of LOFSA. Bellador is in full compliance with all applicable laws and regulations. The regulatory authorities in the Federal Territory of Labuan and in Malaysia are very aggressive in their protection of investors and not at all like the fast and loose jurisdictions that have developed reputations as havens for shady operators.

4. It is patently ridiculous to assert that Bellador would sabotage its own business by causing harm to the share price of Endovasc, Inc. or any other company that it recommends to its clients. Only if Bellador's clients experience consistently good returns will the clients have confidence in Bellador's recommendations. Bellador has an outstanding track record of recommending companies that have experienced success. Not all excellent investment opportunities bear fruit in the first year. Endovasc, for example, was viewed as a 2-3 year opportunity. Bellador has sophisticated clients and it maintains the confidence of those clients, who understand that strong companies can be shorted and that the best remedy is for the company to pursue an unwavering, determined strategy of producing good results.

Bellador has been a strong supporter of the efforts of Endovasc to fight the naked shorting. Anyone who doubts this can call Endovasc and speak with CFO Dwight Cantrell or Vice President for Business Development, Rob Johnson, about their high regard for Bellador and its directors. Mr. Cantrell and Mr. Johnson work with the attorneys for Endovasc in monitoring the naked short selling. They know who is doing it and when it is happening. They absolutely know that Bellador and its clients are a friendly ally and are not part of the problem.

Anyone who doubts the positive direction in which Endovasc is moving and the level of confidence that its investors have in the company should read the press releases linked below. Endovasc has recently reorganized as a Business Development Company and has announced the raise of $5,000,000:

http://biz.yahoo.com/bw/041007/75356_1.html

http://biz.yahoo.com/bw/041007/75357_1.html

Your delight in attacking responsible people and companies and indiscriminately lumping them into a category with bad actors is a destructive way for someone to spend their time on the Internet. You carefully hide behind the anonymity of the Internet. I have no need to do so.

Ronald J. Logan
Logan & Geotas, PLC
Attorneys at Law
Suite 300
2198 E Camelback Rd.
Phoenix, AZ 85016-4747

Office: (602) 957-9320
Internet Fax: (602) 532-7694

Below is an offshorebusiness.com message board post from Peter Taylor of Bellador Group. I mentioned in my original story above that someone coincidentally using the Bellador name as well as his own name coincidentally had been running a stock swap scam between a California bank stretching all the way to Nicosia.Note neither he nor Endovasc's Cantrell ever explain where all those unaudited Envasc shares that are supposed to be traded for AMD shares plus thousands of dollars wired to Nicosia from the California bank came from.But I doubt seriously they were non-existent 'naked shorts'.
Note how he uses the message board, much to David Marchant of offshorebusiness' disapproval, for promotion of his scam.

http://www.offshorebusiness.com/message_board_detail.asp?id=14059&page=4

Bellador Success
By Peter Taylor on 11/10/2004 2:41:34 AM
E-mail: petertaylor@belladorgroup.com

http://www.belladorgroup.com

After the fantastic success of Biophan last year where clients made 233% Bellador seamingly are doing it again with the most recent recommendation American Soyl Technologies SOYL in the last quarter rising 93.24%

About Biophan Technologies

Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The Company develops enabling technologies for implanted medical systems such as pacemakers, and interventional surgical devices such as catheters and guidewires, as well as stents and other implants that can be safely and effectively imaged under MRI. The technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Four Biophan product lines include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors have 21 issued U.S. patents and 71 patents pending, in areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, thermoelectric materials for batteries generating power from body heat, and photonics. Biophan has joint development arrangements with Boston Scientific (NYSE:BSX - News) and NASA's Ames Center for Nanotechnology. Biophan's goal is to make all biomedical devices capable of safely and successfully working with MRI, and delivering other technologies which will improve quality of life.

About American Soil Technologies Inc.

American Soil Technologies develops, manufactures and markets cutting-edge technology that decreases the need for water in agriculture and other plant growing environments while increasing crop yield and reducing the environmental damage caused by common farming practices. The company has an exclusive license to two method patents with cross-linked and linear polymers as their basis. The company also has three patents allowed on a revolutionary new machine, the M-216 Polymer Injector, designed to install its liquid products in mature turf as well as some standing crops. The machine has been built, tested and is now operational.

About Bellador:

Bellador Group carries out substantial investigation of the NASDAQ, OTC:BB and IPO markets to filter out those undervalued situations which demonstrate future potential in their given market sector. We source small and micro cap situations, which are currently under followed.

To find about more about the Bellador Group and the service we provide please visit our website at http://www.belladorgroup.com

Endovasc Scam Warning
Dated: Friday, 9 January, 2004
Dear Client
We have been advised that one of our long-standing Clients has been contacted by a company called Bellador Institutional Services, offering to purchase Endovasc shares in exchange for shares of Advanced Micro Devices.
"Bellador Institutional Services" has no connection with our company, and is being operated as a fraudulent scheme to lure unsuspecting investors into wiring money to an account that has no connection with Bellador Advisory Services (Labuan) Ltd, or Endovasc Inc.
The client received a recommendation that he should exchange stock that he owns in Endovasc, Inc. for stock in Advanced Micro Devices, a company that has a very strong recent trading history. The request included a false claim that this company had inside information about bad news that would soon be released about Endovasc which would allegedly cause the trading price to fall. The client was offered the opportunity to exchange shares of Advanced Micro Devices for Endovasc shares before the release of the alleged bad news, but was told that he would have to wire almost $7,000.00 U.S. to Union Bank of California that would be forward to an account at FBME Limited in Nicosia, Cyprus to complete the transaction.
This is a completely fraudulent scheme by a company that is not connected with the real Bellador Advisory Services (Labuan) Limited. We would never give this type of advice regarding the purchase or sale of securities. It would be a violation of the securities laws of the United States for us to provide information to you from insiders at Endovasc that is not generally available to the investing public and for you to purchase or sell stock based upon that inside information that, when released to the public, might affect the trading price.
This fraudulent company called Bellador Institutional Services has no connection with Bellador Advisory Services (Labuan) Limited. The Peter Taylor who is referenced in the communications from Bellador Institutional Services is not the Peter Taylor who is a director of Bellador Advisory Services (Labuan) Ltd. The money that you may be requested to wire will almost certainly wind up in the hands of criminals in Cyprus rather than being used to pay for shares of stock in a public company called Advanced Micro Devices.
All communications with you by representatives of Bellador Advisory Services (Labuan) Ltd will be from persons at our office who are known to you. All real transactions will be confirmed by the usual Transaction Confirmation letter with instructions for funds to be sent only to trust accounts of Logan & Geotas, PLC., our law firm in Phoenix, Arizona, USA. You will not receive wire transfer instructions that show a bank outside of the United States as a final destination. Cyprus has joined Nigeria and several former Soviet republics as centers of Internet fraud and the recent schemes seem to be targeting sophisticated, high networth investors.
Our Internet technology consultants confirm that we have a secure firewall on our servers and that the confidential information about addresses of our clients who previously purchased Endovasc stock has not been compromised. The matter has been reported to the two banks which were listed on the fraudulent wire transfer instructions.
We have notified Endovasc, Inc. of the attempted fraud. We have requested (and Endovasc has agreed) that all future communications of shareholder addresses between Endovasc and its stock transfer agent be sent by facsimile transmission rather than by e-mail to reduce the chance that confidential information about client addresses could be obtained by the interception of e-mail messages.
Please advise us if you have any concerns or issues with the above information, because we are treating this as a very serious matter and we are also advising our Regulatory Authority LOFSA (Labuan Offshore Financial Services Authority) in respect of this matter.
Bellador Advisory Services (Labuan) Ltd
Client Services Dept

To SEC : James Angel,Georgetown University,Aids Penny Stock Fraud

http://cvilleindymedia.org/newswire.php?story_id=1800

Senator Bennett,penny stock scam,Cheetah Club

http://sandiego.indymedia.org/en/2005/07/110190.shtml

James Dale Davidson,Dubai,and penny stock connections:

http://www.offshorebusiness.com/message_board.asp?search=amenni&submit=Search+text+from+messages/replies

Has Texas Attorney John O'Quinn covered up stock fraud and money laundering ?

http://cvilleindymedia.org/newswire.php?story_id=1788

Judge Ken Reilly,Endovasc and money laundering in Montgomery,Texas

http://www.ntimc.org/newswire.php?story_id=2828&topic=corporateglobalization

Charles Schwab and Share-Money Laundering

http://sfbay.indymedia.org/news/2005/06/1747107.php

Bellador Group related

The answer is we simply don't know but even they would have to admit they may have if they can give no more accounting for Endovasc Ltd.'s,(of Montgomery, Texas), unaudited shares sent to Bellador Group's boiler room in Kuala Lumpur than their Endovasc clients have.

It is Bellador Group's Arizona attorney who 'credits'
Dwight Cantrell and Robert Johnson of Endovasc, with providing an untold quantity of shares for distribution in this terrorist money laundering suspect region of the world.

My previous article-complaints in houston.indymedia and other indymedias have been met by cold silence from all parties involved.I choose here to let my letter to Judge Ken Reilly of today and the SEC filing in question speak for themselves with links to my previous articles,'Has Texas attorney O'Quinn covered up stock fraud and money laundering',as well as,'Judge Ken Reilly,Endovasc and money
laundering in Montgomery,Texas',available to all concerned at the bottom of this release.

Immediately below,and before my most recent letter of record to the Montgomery,Texas judge,is a link to one of the judges own self-promoting websites.It is he,as you can see from his own statements taken from that website,who bills himself not just as a county judge but also as a business and corporate expert including on,'Corporate Directorships - The responsibilities & liabilities of corporate directors.'

And yet he has either allowed his name to be placed erroneously and or fraudulently on an Endovasc SEC filing or has decided to deny it in retrospect.Which is it Judge Ken Reilly ?You can't have it both ways.

And will you now deny knowing Houston's 'famed trail attorney John M. O'Quinn' just as you deny knowing the Beltway's 'anti-naked short' penny stock scamster James Dale Davidson who illegally touted or promoted then dumped his Endovasc shares on defrauded victims ? Does attorney O'Quinn deny knowing James Dale Davidson ? (Do a 'naanss davidson clinton' google search for bits of that story.)

http://www.kenreilly.com/

Looking for a speaker at your next corporate meeting, conference, retreat, or convention?
LOOK NO MORE!!!

KEN REILLY
(NATIONAL SPEAKERS ASSOCIATION - Professional Member)

With over 41 years of professional speaking experience, Hon. Ken Reilly is the perfect presenter for your next event!

Learn More About Ken Reilly

Ken is now accepting speaking engagements for corporate and association events. His presentations include the following:

Keynotes

Environmental Responsibility - The economic benefits of producing environmentally-friendly products

Corporate Directorships - The responsibilities & liabilities of corporate directors
Business Ethics - Public and corporate expectations in the post-Enron era

The History of Golf - A keynote speech for corporate/association golf-related hospitality events

September 20,2005
Dear Judge Ken Reilly,

I have contemplated this portion of the SEC filing below regarding your appointment to the Endovasc Compensation Committee for some time since our last brief communication in 2004 in which you claimed to be helping me get to the truth re Endovasc and my loss of 100% of my investment. Below you will find your correspondence to me.

Also you will find the link to the 10QSB of 2003 announcing that, 'on September 21, 2002, the Board considered the appointments of an Audit and Compensation Committee. The Board unanimously appointed Judge Ken Reilly as Chairman of the Compensation Advisory Board...' So I am asking simply, is this true or is the SEC filing in error ?

I am in the process of putting some writing together not only on the fraudulent claim made by David P Summers and attorney O'Quinn re naked shorting that I believe was used to divert attention from illegal pumps and dumps by Endovasc and the approval by Dwight Cantrell of a Schwab account of 'up to 30 million shares' in May 2002, even before the fraudulent 'reverse split' that should have
left under 3 million shares in July,but also a boiler room deal with Bellador Group of Kuala Lumpur that also has ties to Dubai.Money laundering,even for terrorist activities may have been involved.

I also have reason to believe James Dale Davidson who now appears to have Middle East connections may have been involved in the Bellador Group boiler room deal as well.I am almost positive he was involved in the Schwab pump and dump account that may have been Schwab's LOM of Bermuda account.Mr.Davidson had recommended LOM in his book,'The Sovereign Individual',without disclosing at the time he was a substantial share holder.

While I would appreciate any help or information you might give me regarding these affairs I particularly wish an answer as to whether the SEC filing was correct or in error regarding your appointment to the 'Compensation Committee.You might also do me favor and request that Endovasc's 'management' insist insiders with aliases diffdrummer0,meangene53, slowbrain and kingorschmuck,etc.,cease and desist from further fraudulent touting of EVSC and EVSD shares on ragingbull.com.

I am glad to quote verbatim any comments you may have re the fraud called Endovasc of Montgomery, Texas AND YOUR ACKNOWLEDGEMENT OR REBUTTAL ABOUT THE ACCURACY OF THE SEC FILING USING YOUR NAME.But I am anxious to finish the article I have already begun.You may find more re Bellador Group andan Arizona attorney named Logan who works for them by asking Dwight Cantrell and Robert Johnson or I can give you contact information and statements by them if you like.

Bellador Group's Mr.Taylor and Mr.Logan acknowledge having made a deal with Cantrell and Johnson but this is not mentioned in Endovasc SEC filings.Why ? Bellador Group has a bad reputation in Hong Kong and citizens there have been warned to stay away by Hong Kong government.And even Belladorgroup.com placed a 'scam warning' re transactions involving Endovasc shares in early 2004.Were you aware of this ?

So you see I am not only in shock at the fraud and internet cyberfraud against me that I have literally paid for,I have rewarded these scamsters in Montgomery,Texas for harrssing and tormenting for years over the internet and in being conned by a Stanford patent,but as an American totally distaught in this post 911 era to know that my money was used in what appears to be a money laundering operation with unaudited U.S.penny stock shares in Kuala Lumpur with ties to Dubai among other places.I'm sorry Robert Johnson,et.al., can't think of another way to get himself some 'cowboy boots'.

Sincerely,
Tony Ryals

P.S.- The reason my email account has changed and the account you are replying to is not in my name is precisely because my biodog0 account at Yahoo was deleted by the very penny stock mafia I am fighting there as well.

Judge Ken Reilly personal communication from 2004:

Reillytalk (at) aol.com wrote:
Dear Mr. Ryals:

There has been a substantial amount of misinformation posted on Raging Bull and relating to EVSC. Perhaps this response will help you to know a bit more of the truth.

I have never been a member of the Endovasc Audit Committee or any other Audit Committee associated with this firm or its predecessors or affiliates.
I have never received compensation of any form for service on any Audit Committee.
I am not now and never have been an Officer, Director or Employee of any of said firms.

I do not know Mr. James Dale Davidson, have never met him or done any business with him.I have no personal knowledge regarding Mr. Davidson association with any of said firms.
I have occasionally provided Legal Counsel to Endovasc. I am unable to share any of that information with you as you are not my client.

It is regrettable that you have suffered a financial loss due to your investment in Endovasc;however, I am not a good source of any further information and request that you cease and desist in your contacts with me or published comments about me.

I have practiced my profession honorably for the past 43 years ( as you learned in your Bar Assn search). I intend to continue to abide by the Lawyers Cannon of Ethics.
I learned many years ago that practicing Attorneys often make good targets for their unlicensed opponent's criticism. However, the Law does provide adequate remedy for libelous assertions.

Mr. Ryals, you seem like an intelligent fellow. Don't minimize your effectiveness by repeating gossip.

Respectfully yours,

Ken Reilly

tony ryals wrote:
Dear Ken Reilly,Thanks much for your reply.Had you noticed earlier that Mr.s Cantrell and Summers were using your name on their website to add 'credibilty to their 'company' I am sure you would have acted sooner to inform unwary 'investors'. I sure wish I knew just who the insiders are who have used and use ragingbull to promote their fraud.
Sincerely,
Tony Ryals

From 2003 SEC filing with link :

Judge Ken Reilly,Chairman of the Compensation Advisory Board

http://www.sec.gov/Archives/edgar/data/1040415/000101540203001859/0001015402-03-001859.txt

At a special meeting of the Board of Directors held on September 21, 2002, theBoard considered the appointments of an Audit and Compensation Committee. The Board unanimously appointed Judge Ken Reilly as Chairman of the Compensation Advisory Board and Ken Beverly
as Chairman of the Audit Advisory Committee to the Board of Directors. Previously announced Beuttenmuller, Bagrier and Davidson, were made prior to the Sarbanes/Oxley Act, and were rescinded by the Board until further review by the respective Chairman. On November 18, 2002, the annual shareholders meeting took place at the Del Lago Hotel and Resort,Montgomery, Texas, with all issues placed before the shareholders approved for the coming year. In November and December 2002, the Company awarded contracts to two (2) certified good manufacturing (cGMP) contract
laboratories to manufacture and validate both of the Company's pending Phase III drugs. Upon completion and validation of each of the drugs for FDA requirements, an initialnew drug application (IND) will be filed with the FDA for Phase III clinical trials. As of March 31, 2003, the products have been produced and are pending
cGMP release in June 2003 for Phase III trials on Liprostin. Phase III trials for Angiogenix are expected to commence in the quarter ended December 31, 2003.

RESULTS OF OPERATIONS
- -----------------------

THREE MONTH PERIODS ENDED MARCH 31, 2003 AND 2002
- ---------------------------------------------------------

During the three months ended March 31, 2003, the Company had revenue of $94,000 compared with $161,000 of revenues for the three months ended March 31,2002. The revenue during the three months ended March 31, 2003 was a result ofrevenue received for funding its research and development costs related to itsNicotine Receptor Agonist and stent coating processes.

During the three months ended March 31, 2003 and 2002, administrative andoperating expenses were $549,000 and $249,000, respectively. The increase incosts and operating expenses is primarily due to an increase in stock based
compensation to third party consultants during the three months ended March 31,2003.

Research and development costs totaled $1,032,000 during the three months ended March 31, 2003, compared to $245,000 during the three months ended March 31, 2002. This increase of $787,000 was related to the increased cost ofmaterials, labor and travel associated with the preparation for Phase III clinical studies with Liprostin (TM) and the ongoing, in-house projects for medicinally coated vascular stents and a biodegradable resorbable stent.

Interest expense decreased from $14,000 during the three months ended March 31, 2002 to $4,000 during the three months ended March 31, 2003. This decrease is a result of a lower average debt balance and lower interest rates.

NINE MONTH PERIODS ENDED MARCH 31, 2003 AND 2002
- --------------------------------------------------------

During the nine months ended March 31, 2003, the Company had total revenues of $293,000 compared with $407,000 of revenues for the nine months ended March 31, 2002. The decrease relates to less revenue received from an external
research agreement with another company entered into in July 2001 whereby the Company received assistance in funding its research and development costs related to its Nicotine Receptor Agonist.

During the nine months ended March 31, 2003 and 2002, administrative and operating expenses were $3,328,000 and $913,000, respectively. The increase in costs and operating expenses is primarily due to an increase in
facilities cost,personnel, including stock based compensation paid to third party consultants
and attorneys, and overhead as rent and other costs increased.

Research and development costs totaled $2,338,000 during the nine months ended March 31, 2003, compared to $984,000 during the nine months ended March 31, 2002. This increase of $1,354,000 was related to the increased cost of
materials, labor and travel related to the preparation for Phase III clinical studies with Liprostin (TM) and the ongoing, in-house projects for medicinally coated vascular stents and a biodegradable resorbable stent.

Interest expense decreased from $207,000 during the nine months ended March 31, 2002 to $51,000 during the nine months ended March 31, 2003. This decrease
is primarily a result of the cost of the beneficial conversion feature related to the convertible debentures recorded during the nine months ended March 31,
2002 of $171,000.

LIQUIDITY AND CAPITAL RESOURCES
- ----------------------------------

The Company had a working capital deficit at March 31, 2003 of $(540,000), compared to a deficit of $(736,000) at December 31, 2002. This decrease in the working capital deficit is primarily related to the decrease in
accounts payable resulting from the issuance of common stock for payment of accounts payable during the nine months ended March 31, 2003.

The Company requires significant additional funds to enable it to proceed with its two Phase III Liprostin(TM) and Phase III ANGIOGENIX(TM) clinical trials.

The Company continues to actively pursue additional financing,collaborations with firms, and other arrangements aimed at increasing its capital resources. Failure to acquire such funds may adversely impact the
scheduled marked introduction of Liprostin(TM) and ANGIOGENIX(TM) and possibly adversely affect the Company's operations. In order to continue as a going concern, the Company must raise additional funds and ultimately achieve profit from its operation; however, there can be no assurance that the Company will obtain profitability or that future debt or equity funding will be
available or have terms acceptable to the Company. These factors raise substantial doubt as to the Company's ability to continue as a going concern. The report of the
Company's independent public accountants, which accompanied the financial statements for the year ended June 30, 2002, was qualified with
respect to that risk.

CRITICAL ACCOUNTING POLICIES
- ------------------------------

RESEARCH AND DEVELOPMENT
- --------------------------

Research and development costs are expensed as incurred. These costs consist of direct and indirect costs associated with specific projects.

STOCK-BASED COMPENSATION
- -------------------------

Stock-based compensation is accounted for using the intrinsic value mathod prescribed in Accounting Principles Board Opinion ("APB") No. 25, "Accounting for Stock Issued to Employees", rather than applying the fair value method
prescribed in SFAS No. 123, "Accounting for Stock-Based Compensation".

LOSS PER SHARE
- ----------------

Basic and diluted loss per share is computed on the basis of the weighted average number of shares of common stock outstanding during each period. Common equivalent shares from common stock options and warrants and Series A, B and C convertible preferred stock are excluded from the computation as their effect would dilute the loss per share for all periods presented.

ITEM 3. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
- ------- -----------------------------------------------------

David P. Summers, Chief Executive Officer of the Company & M.Dwight Cantrell, Chief Financial Officer of the Company, have concluded that their disclosure controls and procedures are appropriate and effective. They have
evaluated the controls and procedures as of a date within 90 days of the filing date of this report on Form 10-QSB. There were no significant changes in our internal controls or in other factors that could significantly affect these
controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS
- ------- ------------------

On September 11, 2002 the company filed a civil lawsuit styled Endovasc Ltd., Inc v. J.P. Turner & Co. LLC et al, Number 02-CV-7313, in the United States District Court, Southern District of New York. The complaint is for damages as a result of an alleged fraud and stock manipulation. The company is seeking monetary damages in excess of $200,000,000. In a related matter, a show cause complaint was filed against the Company on September 19, 2002 styled Balmore SA etal v Endovasc Ltd., Inc. A hearing was held on September 26, 2002 with the Judge issuing an unfavorable ruling against the Company. The
matter was settled through the issuance of 203,000 shares of the Company's common stock. In another related matter, a show cause complaint was filed against the Company on October 17, 2002 styled Laurus Master Fund Ltd. et al v Endovasc Ltd, Inc., Number 02- CV-8317, in the United States District Court, Southern District of New York. This suit involves the issuance of 430,476 shares of stock. This matter was settled through the issuance of the Company's common stock to retire Series A Preferred Convertible stock. In another related matter the Company has become a defendant in arbitration styled V Finance v. Endovasc Ltd., Inc. This matter relates to performance under a Funding Agreement. The Company intends to defend its position vigorously as it believes it will prevail and,accordingly, has not accrued any liability associated with this case in the accompanying unaudited condensed financial statements.

ITEM 2. CHANGES IN SECURITIES
- ------- -----------------------

Recent Sale of Unregistered Securities. During the nine months ended March 31, 2003, the following transactions were effected by us in reliance upon exemptions from registration under the Securities Act of 1933 as amended (the "Act"). Unless stated otherwise, we believe that each of the persons who received these unregistered securities had knowledge and experience in financial and business matters which allowed them to evaluate the merits and risk of the receipt of these securities, and that they were knowledgeable about our operations and financial condition. No underwriter participated in, nor did we pay any commissions or fees to any underwriter in connection with the transactions. These transactions did not involve a public offering. Each certificate issued for these unregistered securities contained a legend stating that the securities have not been registered under the Act and setting forth the restrictions on the transferability and the sale of the securities.

During the 9 month period ending March 31, 2003 we issued an aggregate of 3,530,460 shares of common stock for services, which we valued at prices ranging from $0.62 to $2.19 per share, with an aggregate value of $4,060,000. These
transactions were exempt from registration pursuant to Section 4(2)
of the Act.

During the 9 month period ending March 31, 2003 we issued an aggregate of 284,835 shares of common stock for cash at prices ranging from $0.82 to $0.95 per share, with an aggregate value of $266,000. These transactions were exempt
from registration pursuant to Section 4(2) of the Act.

During the 9 month period ending March 31, 2003 we issued 2,179,562 shares of common stock for exercise of warrants with an average exercise price of $0.26 per share and $560,000 in the aggregate. These transactions were exempt from registration pursuant to Section 4(2) of the Act.

During the 9 month period ending March 31, 2003 we issued a total of31,542,345 shares of common stock upon the conversion of preferred stock and dividends on preferred stock. We did not receive any proceeds from these transactions. These transactions were exempt from registration pursuant to Section 4(2) of the Securities Act.

roulette download slots download poker download casino download

roulette online slots online poker online casino online

free party poker optimum play poker video triple play video poker free three card poker game full tilt poker freeroll bellagio poker chips nexgen poker chips free plamate poker room online poker win online poker prize

world series of poker chips poker satellite tour tournament world 2006 player poker series world holdem intelligent poker texas 2006 poker series tv world 2 download poker superstars odds poker series world

free game machine poker play free poker poker tournament in las vegas casino free gambling play poker live poker players erotic game strip poker

tetrazepam online buy tetrazepam online buy duofem online duofem online buy zocor online zocor online buy alium online valium online buy fluoxetin online fluoxetin online buy clarithromycin online clarithromycin online buy tranxilium online ranxilium online buy presomen online presomen online buy buspiron online buspiron online buy praxiten online praxiten online buy xenical online xenical online buy menogon online menogon online buy yasmin online yasmin online buy pirazetam online pirazetam online buy amantadin online amantadin online buy zoloft online zoloft online buy migraeflux online migraeflux online buy metamizol online metamizol online buy oxazepam online oxazepam online buy enalapril online enalapril online buy xatral online xatral online buy actos online actos online buy climopax online climopax online buy librium online librium online buy omeprazol online buy omeprazol online amlodipin online buy amlodipin online buy clonidin online clonidin online buy relpax online relpax online buy singulair online singulair online buy isotret online isotret online buy azur online azur online buy somadril online somadril online buy zithromax online zithromax online buy lorazepam online lorazepam online buy alprazolam online alprazolam online buy amaryl online amaryl online buy codeinum online codeinum online buy klipal online klipal online buy diane online diane online buy clomipramin online clomipramin online buy cipralex online cipralex online buy zolpidem online zolpidem online buy reductil online reductil online buy zomig online zomig online buy valtrex online valtrex online buy codiovan online codiovan online buy tramadol online tramadol online buy metformin online metformin online buy cialis online cialis online buy norvasc online norvasc online buy allopurinol online allopurinol online buy xanax online xanax online buy furorese online furorese online buy nuva online nuva online buy avodart online avodart online buy sortis online sortis online buy penicillin online penicillin online paracetamol online buy paracetamol online buy levitra online levitra online buy spiriva online spiriva online buy clomifen online clomifen online buy proscar online proscar online buy tenormin online tenormin online buy atehexal online atehexal online buy zyban online zyban online buy evra online evra online buy glucophage online glucophage online buy ortoton online ortoton online buy arcoxia online arcoxia online buy citalopram online citalopram online buy glucobay online glucobay online buy crestor online crestor online buy bella online bella online buy tavor online tavor online buy tamiflu online tamiflu online buy viagra online viagra online buy mianserin online mianserin online buy serevent online serevent online buy stilnox online stilnox online buy promethazin online promethazin online buy spasmorelax online spasmorelax online buy gelonida online gelonida online buy verapamil online verapamil online buy ezetrol online ezetrol online buy mirtazapin online mirtazapin online buy atemur online atemur online buy propecia online propecia online buy strattera online strattera online buy tramadolor online tramadolor online buy noctamid online noctamid online buy zyrtec online zyrtec online buy avandia online avandia online buy agopton online agopton online buy effexor online effexor online buy paroxat online paroxat online buy flixotide online flixotide online buy sirdalud online sirdalud online buy maxalt online maxalt online buy planum-temazepam online planum-temazepam online buy combaren online combaren online buy rivotril online rivotril online buy fevarin online fevarin online buy zopiclon online zopiclon online buy furosemid online furosemid online buy ibuprofen online ibuprofen online buy triarese online triarese online buy paroxetin online paroxetin online buy quinapril online quinapril online buy dormicum online dormicum online buy metoprolol online metoprolol online buy diltahexal online diltahexal online buy meglucon online meglucon online buy remeron online remeron online buy ramipril online ramipril online buy catapresan online catapresan online regenon online buy regenon online trazodon online buy trazodon online celebrex online buy celebrex online lisinopril online buy lisinopril online cipramil online buy cipramil online dalmadorm online buy dalmadorm online yelfast online buy yelfast online voltaren online buy voltaren online buy lisihexal online lisihexal online buy simvastatin online simvastatin online buy sonata online sonata online buy adekin online adekin online buy diazepam online diazepam online buy biaxin online biaxin online buy tenuate online tenuate online buy amitriptylin online amitriptylin online tetrazepam online buy tetrazepam online buy duofem online duofem online buy zocor online zocor online buy alium online valium online

aciphex online acyclovir online albenza online aldactone online aldara online alesse online allegra online allegrad online amoxicillin online bentyl online carisoprodol online clarinex online colchicine online denavir online diproleneaf online elimite online eurax online fioricet online flonase online gris-peg online kenalogaerosol online levbid online lipitor online motrin online nasacortaq online nizoral online orthotricyclen online penlac online propecia online prozac online renova online skelaxin online synalar online temovate online tramadol online ultracet online vaniqa online wellbutrin online yasmin online zoloft online buy aciphex buy acyclovir buy albenza buy aldactone buy aldara buy alesse buy allegra buy allegrad buy amoxicillin buy bentyl buy carisoprodol buy clarinex buy colchicine buy denavir buy diproleneaf buy elimite buy eurax buy fioricet buy flonase buy gris-peg buy kenalogaerosol buy levbid buy lipitor buy motrin buy nasacortaq buy nizoral buy orthotricyclen buy penlac buy propecia buy prozac buy renova buy skelaxin buy synalar buy temovate buy tramadol buy ultracet buy vaniqa buy wellbutrin buy yasmin buy zoloft aciphex acyclovir albenza aldactone aldara alesse allegra allegrad amoxicillin bentyl carisoprodol clarinex colchicine denavir diproleneaf elimite eurax fioricet flonase gris-peg kenalogaerosol levbid lipitor motrin nasacortaq nizoral orthotricyclen penlac propecia prozac renova skelaxin synalar temovate tramadol ultracet vaniqa wellbutrin yasmin zoloft

nice news ! i'm find on the net, news about pharmacy Titretta and pills online | | pills.org

fresh news and information about please see.. thanks || tetracycline || buy tramadol fresh news and information about please see.. thanks || tetracycline || buy tramadol fresh news and information about please see.. thanks || tetracycline || buy tramadol fresh news and information about please see.. thanks || tetracycline || buy tramadol

help children! if you search for London Hotel and any thing SEARCH FOR HELP all incomes will go for the needs of children.email this and say to your friends! Thanks

help children! if you search for Internet Poker and any thing SEARCH FOR HELP all incomes will go for the needs of children.email this and say to your friends! Thanks

help children! if you search for Mortgage Company and any thing SEARCH FOR HELP all incomes will go for the needs of children.email this and say to your friends! Thanks

help children! if you search for Health Insurance and any thing SEARCH FOR HELP all incomes will go for the needs of children.email this and say to your friends! Thanks